Unilateral primary or secondary end-stage knee lesions
Conditions
Interventions
Control Group:Traditional cobalt-chromium-molybdenum alloy artificial knee joint
Experimental Group:A new zirconia niobium alloy is used for artificial knee joints
Sponsors
Shanghai Jiao Tong University of Medicine affiliated Ninth People's Hospital
Eligibility
Sex/Gender
All
Age
60 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Through clinical examination and imaging examination, unilateral primary or secondary end-stage knee lesions are determined; 2. Age 60-80 years old (including 60 and 80 years old); 3. The study participant himself or his legal representative voluntarily receives the treatment and signs the "Informed Consent Form".
Exclusion criteria
Exclusion criteria: 1.Persons who are unable to tolerate surgery in systemic conditions; 2.Patients with bilateral osteoarthritis; 3.Active infection; 4.Combined with other systemic bone or joint deformities; 5.The patient's preoperative CT and X-ray data were incomplete; 6. Patients do not agree to participate in this clinical trial study, and other researchers believe that it is not suitable to participate in this trial study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Placement rate of artificial total knee prosthesis;Levels of IL-6; | — |
Countries
China
Contacts
Public ContactLiao Wang
Shanghai Jiao Tong University of Medicine affiliated Ninth People's Hospital
Outcome results
None listed